Title:
FGFR2 INHIBITOR AND METHOD FOR USING SAME
Document Type and Number:
WIPO Patent Application WO/2023/202625
Kind Code:
A1
Abstract:
Provided in the present invention are a highly selective FGFR2 inhibitor, a preparation method therefor, the use thereof, a pharmaceutical composition containing the compound or a salt thereof, and a method for treating various diseases mediated by FGFR2 in various different forms by means of using the compound and the salt thereof, wherein the diseases comprise intrahepatic cholangiocarcinoma, gastric cancer, etc.
Inventors:
ZHU CHENGGANG (CN)
YANG XUAN (CN)
ZHANG CHAOCHUN (CN)
WANG CHUNNIU (CN)
WANG QIANWEN (CN)
CHEN CHAOLE (CN)
XU LIANGLIANG (CN)
YANG XUAN (CN)
ZHANG CHAOCHUN (CN)
WANG CHUNNIU (CN)
WANG QIANWEN (CN)
CHEN CHAOLE (CN)
XU LIANGLIANG (CN)
Application Number:
PCT/CN2023/089242
Publication Date:
October 26, 2023
Filing Date:
April 19, 2023
Export Citation:
Assignee:
SHENZHEN FORWARD PHARMACEUTICALS CO LTD (CN)
International Classes:
C07D487/14
Foreign References:
| CN114126620A | 2022-03-01 | |||
| CN1259950A | 2000-07-12 | |||
| US20040043403A1 | 2004-03-04 | |||
| CN1326457A | 2001-12-12 | |||
| CN103582643A | 2014-02-12 |
Attorney, Agent or Firm:
WU , FENG & ZHANG (CN)
Download PDF: